London

New Business

HSBC asks Hang Seng Bank to clean up bad Hong Kong property debt

HSBC Holdings has taken the unusual step of getting directly involved in pushing its Hong Kong subsidiary, Hang Seng Bank,…

Read More »
New Business

Canada’s RBC BlueBay partners with Endowus to expand asset manager’s Asia presence

RBC BlueBay Asset Management, a unit of the Royal Bank of Canada, has formed a partnership with digital-wealth platform Endowus…

Read More »
New Business

Nvidia CEO Jensen Huang says he is disappointed by China’s reported chip curbs

The CEO of Nvidia, which faces tight restrictions on selling its chips to China amid the Sino-US battle over trade…

Read More »
New Business

In Washington, China’s top trade negotiator readies for talks, but no formal negotiations

One of China’s top trade negotiators, Li Chenggang, will be meeting with relevant US officials this week while in Washington,…

Read More »
New Business

Prudential’s new business profit jumps 12% on increase in Hong Kong sales

British insurer Prudential reported strong first-half results on robust growth in key markets from Hong Kong to Indonesia. New business…

Read More »
New Business

Pop Mart’s interim sales soar as Labubu craze fuels Chinese toymaker’s record earnings

Pop Mart established itself as the world’s most valuable toy producer and exporter of China’s “soft power” after the global…

Read More »
New Business

Trump’s chip deal signals a new ‘pay-to-play’ China trade policy, analysts say

US President Donald Trump’s “unprecedented” deal to allow exports of some advanced chips to China in exchange for a cut…

Read More »
New Business

Hong Kong’s Peninsula Hotels sees ‘bleisure’ boom after pandemic curbs, CEO says

Hong Kong has welcomed a new wave of travellers combining business and leisure, who have revitalised the city’s luxury hotel…

Read More »
New Business

For the US, it’s Mountain Pass – or fail – in bid to supplant China’s rare earth supremacy

Rare earths are needed for everything from consumer electronics to electric vehicles, wind turbines and fighter jets – and China…

Read More »
New Business

GSK signs US$12.5 billion licence deal with Hengrui as China rises in global pharmaceuticals

GlaxoSmithKline (GSK) will pay a Chinese company US$12.5 billion for exclusive global rights to develop a dozen drugs, in a…

Read More »
Back to top button